3D Medicines Inc.
1244 · HKEX
Public Market Listing
Live quotes, historical charts, and market capitalization for 3D Medicines Inc. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | PD-L1Monoclonal antibody | HIVNon-Small Cell Lung CancerChronic Hepatitis BEndometrial Cancer | |
| Phase 3 | WT1 (Wilms Tumor-1 protein)Vaccine | Acute Myeloid LeukemiaMultiple Myeloma |
Upcoming events
(5 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (2)
December 2026 (2)
What to watch
What to watch
2027 (2)
2029 (1)
June 2029 (1)
What to watch
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent